Schedule 13D ownership disclosure

EIDOS THERAPEUTICS INC

Security class unavailable · CUSIP: 28249H104

Event date: 2018-06-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-036981
Form type
SC 13D
Filer
Eidos Therapeutics, Inc.
CIK
CIK 1731831
Filed
Jul 02, 2018
Reporting period
Jun 22, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub